Inherited myopathies and muscular dystrophies

Seminars in Neurology

Volumn 28, Issue 2, 2008, Pages 250-259

  Cardamone, Michael ^a   Darras, Basil T ^b,c   Ryan, Monique M ^a,d,e  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Muscular dystrophy; Myopathy; Pediatric

Indexed keywords

CISAPRIDE; COLESTYRAMINE; METOCLOPRAMIDE;

ANESTHESIA; BULBAR PARALYSIS; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; ELECTRONEUROLOGY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEEDING DISORDER; GASTROINTESTINAL DISEASE; GENETIC ANALYSIS; HEART DISEASE; HEREDITY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MALABSORPTION; MORBIDITY; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; MYOTONIC DYSTROPHY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; STOMACH EMPTYING;

DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL;

EID: 41149151436     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1062269     Document Type: Review

References (63)

1. Ryan MM, North KN. Congenital myopathies. In: Noseworthy J, ed. Neurological Therapeutics: Principles and Practice. Rochester, NY: Martin Dunitz; 2006:2607-2618
2. Yates JR, Emery AE. A population study of adult onset limb-girdle muscular dystrophy. J Med Genet 1985;22:250-257
3. Wallgren-Pettersson C, Beggs AH, Laing NG. 51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The Netherlands. Neuromuscul Disord 1998; 8:53-56
4. Clarke NF, North KN. Congenital fiber type disproportion: 30 years on. J Neuropathol Exp Neurol 2003;62:977-989
5. Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord 1991;1:19-29
6. Mostacciuolo ML, Miorin M, Martinello F, et al. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet 1996;97:277-279
7. Emery AEH. Duchenne Muscular Dystrophy. 2nd ed. New York: Oxford University Press; 1993
8. Bushby KM, Thambyaya M, Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991;337:1022-1024
9. Harper PS. Myotonic Dystrophy. 3rd ed. London: WB Saunders Company; 2001
10. Padberg G. Facioscapulohumeral Disease. Leiden, The Netherlands: International Graphics, University of Leiden; 1982
11. Urtasun M, Saenz A, Roudaut C, et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque country, Spain). Brain 1998;121:1735-1747
12. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy: familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids. N Engl J Med 1962;267:1267-1272
13. Shy GM, Magee KR. A new congenital non-progressive myopathy. Brain 1956;79:610-621
14. Dubowitz V. The "new" myopathies. Neuropediatrics 1969;1:137-148
15. Ryan MM, Schnell C, Strickland CD, et al. Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 2001;50:312-320
16. Quinlivan RM, Muller CR, Davis M, et al. Central core disease: clinical, pathological, and genetic features. Arch Dis Child 2003;88:1051-1055
17. McEntagart M, Parsons G, Buj-Bello A, et al. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord 2002;12:939-946
18. Mastaglia FL, Lamont PJ, Laing NG. Distal myopathies. Curr Opin Neurol 2005;18:504-510
19. Muntoni F, Voit TC. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord 2004;14:635-649
20. Quijano-Roy S, Renault F, Romero N, et al. EMG and nerve conduction studies in children with congenital muscular dystrophy. Muscle Nerve 2004;29:292-299
21. Jones K, North K. The congenital muscular dystrophies. In: Jones HR, De Vivo DC, Darras BT, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Philadelphia: Butterworth Heinemann; 2003:633-634
22. Darras BT. Muscular dystrophies. Continuum 2006;12:33-75
23. Wicksell RK, Kihlgren M, Melin L, Eeg-Olofsson O. Specific cognitive deficits are common in children with Duchenne muscular dystrophy. Dev Med Child Neurol 2004;46:154-159
24. Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol 2005;26:66-72
25. Bushby KM, Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy: I. Natural history. J Neurol 1993;240:98-104
26. Gedeon AK, Wilson MJ, Colley AC, Sillence DO, Mulley JC. X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. J Med Genet 1995;32:383-388
27. Sunohara N, Arahata K, Hoffman EP, et al. Quadriceps myopathy: forme fruste of Becker muscular dystrophy. Ann Neurol 1990;28:634-639
28. Gospe SM, Lazaro RP, Lava NS, et al. Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene. Neurology 1989;39:1277-1280
29. Hoogerwaard EM, van der Wouw PA, Wilde AA, et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999;9:347-351
30. Hoffman EP, Arahata K, Minetti C, Bonilla E, Rowland LP. Dystrophinopathy in isolated cases of myopathy in females. Neurology 1992;42:967-975
31. Darras BT. Molecular genetics of Duchenne and Becker muscular dystrophy. J Pediatr 1990;117:1-15
32. Hoffman EP, Kunkel LM. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 1989;2:1019-1029
33. Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320:1592-1597
34. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2004;(2):CD003725
35. Moxley RT III, Ashwal S, Pandya S, et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005;64:13-20
36. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19
37. Nowak KJ, Davies KE. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 2004;5:872-876
38. Griggs RC, Davis RJ, Anderson DC, Dove JT. Cardiac conduction in myotonic dystrophy. Am J Med 1975;59:37-42
39. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808
40. English KM, Gibbs JL. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol 2006;48:231-235
41. van Engelen BG, Brunner HG. Gastrointestinal dysfunction in myotonic dystrophy. In: Harper PS, van Engelen B, Eymard B, Wilcox DE, eds. Myotonic Dystrophy: Present Management, Future Therapy. New York: Oxford University Press; 2004
42. Ricker K, Koch MC, Lehmann-Horn F, et al. Proximal myotonic myopathy: clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31
43. Rowland LP, Fetell M, Olarte M, et al. Emery-Dreifuss muscular dystrophy. Ann Neurol 1979;5:111-117
44. Bione S, Maestrini E, Rivella S, et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994;8:323-327
45. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999;21:285-288
46. Raffaele Di Barletta M, Ricci E, Galluzzi G, et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2000;66:1407-1412
47. Tawil R, Figlewicz DA, Griggs RC, et al. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium. Ann Neurol 1998;43:279-282
48. Ketenjian AY. Scapulocostal stabilization for scapular winging in facioscapulohumeral muscular dystrophy. J Bone Joint Surg Am 1978;60:476-480
49. Diab M, Darras BT, Shapiro F. Scapulothoracic fusion for facioscapulohumeral muscular dystrophy. J Bone Joint Surg Am 2005;87:2267-2275
50. Bushby KM. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 1995;5:71-74
51. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculo-pharyngeal muscular dystrophy. Nat Genet 1998;18:164-167
52. Shapiro F, Specht L. The diagnosis and orthopaedic treatment of childhood spinal muscular atrophy, peripheral neuropathy, Friedreich ataxia and arthrogryposis. J Bone Joint Surg Am 1993;75:1699-1714
53. Hsu JD. The development of current approaches to the management of spinal deformity for patients with neuromuscular disease. Semin Neurol 1995;15:24-28
54. Wazeka AN, DiMaio MF, Boachie-Adjei O. Outcome of pediatric patients with severe restrictive lung disease following reconstructive spine surgery. Spine 2004;29:528-534
55. Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type 1: a noninvasive respiratory management approach. Chest 2000;117:1100-1105
56. Mellies U, Ragette R, Schwake C, et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001;57:1290-1295
57. Young HK, Lowe A, Fitzgerald DA, et al. Non-invasive ventilation in children with neuromuscular disease: a clinical and quality of life outcome study. Neurology 2007;68:198-201
58. McCarthy TV, Quane KA, Lynch PJ. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 2000;15:410-417
59. Ryan MM, Ilkovski B, Strickland CD, et al. Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology 2003;60:665-673
60. Brei TJ. Management of drooling. Semin Pediatr Neurol 2003;10:265-270
61. Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol 2003;16:577-583
62. Lewis WR, Yadlapalli S. Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 1998;9:145-166
63. Tawil R. Outlook for therapy in the muscular dystrophies. Semin Neurol 1999;19:81-86